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ABSTRACT
Background COVID-19 has caused a global public 
health crisis affecting most countries, including Ethiopia, 
in various ways. This study maps the vulnerability to 
infection, case severity and likelihood of death from 
COVID-19 in Ethiopia.
Methods Thirty- eight potential indicators of vulnerability 
to COVID-19 infection, case severity and likelihood of 
death, identified based on a literature review and the 
availability of nationally representative data at a low 
geographic scale, were assembled from multiple sources 
for geospatial analysis. Geospatial analysis techniques 
were applied to produce maps showing the vulnerability to 
infection, case severity and likelihood of death in Ethiopia 
at a spatial resolution of 1 km×1 km.
Results This study showed that vulnerability to COVID-19 
infection is likely to be high across most parts of Ethiopia, 
particularly in the Somali, Afar, Amhara, Oromia and Tigray 
regions. The number of severe cases of COVID-19 infection 
requiring hospitalisation and intensive care unit admission 
is likely to be high across Amhara, most parts of Oromia 
and some parts of the Southern Nations, Nationalities and 
Peoples’ Region. The risk of COVID-19- related death is 
high in the country’s border regions, where public health 
preparedness for responding to COVID-19 is limited.
Conclusion This study revealed geographical differences 
in vulnerability to infection, case severity and likelihood of 
death from COVID-19 in Ethiopia. The study offers maps 
that can guide the targeted interventions necessary to 
contain the spread of COVID-19 in Ethiopia.
INTRODUCTION
COVID-19 has become one of the most 
serious global public health crises in modern 
times.1 The disease was declared a pandemic 
on 11 March 2020 and has currently affected 
more than 216 countries and territories.2 
As of 3 August 2020, there were more than 
17.6 million confirmed COVID-19 cases and 
over 680 000 associated deaths around the 
globe.3 The highest numbers of cases and 
deaths have been reported from the USA, 
Brazil, India and some European countries, 
such as Russia, the UK, Italy and Spain.3 
African countries, including Ethiopia, 
have reported a low number of COVID-19, 
although the number of cases and deaths 
are currently on the rise.4 In Ethiopia, the 
first case of COVID-19 was reported on 13 
March 2020 in Addis Ababa, but at the time 
of this study almost all regions of the country 
were affected by COVID-19 at different 
Strengths and limitations of this study
 ► This is the first study that maps vulnerability to 
COVID-19 infection, severe cases and associated 
death in Ethiopia at a high level of resolution across 
the entire territory of Ethiopia.
 ► This is also the first study that has attempted to 
present the degree of service preparedness for 
COVID-19 across the country.
 ► The study incorporated a wide range of indicators 
from multiple sources and applied rigorous geospa-
tial techniques to provide the best possible predic-
tion maps.
 ► However, some important indicators such as psy-
chosocial and clinical factors were not captured in 
our modelling due to the lack of geocoded data.
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magnitudes.5 However, the number of cases in Ethiopia is 
still very low due to limited testing capacity and delays in 
reporting confirmed cases.
Multiple factors, such as sociodemographic, connec-
tivity, behavioural, climatic and comorbidity factors, are 
strong predictors of the differences in transmission, 
hospitalisation and mortality rates among and within 
countries.6 7 Studies conducted in Africa have provided 
limited information on the vulnerability of different 
areas to COVID-19 infection.4 8 These studies have been 
conducted at the country level using a limited number 
of indicators.4 8 Mapping the risks of COVID-19 (infec-
tion, case severity, service preparedness and death) at the 
lowest administrative unit, such as the district, is important 
in many ways. First, the generated evidence can help the 
government and community better prepare and respond 
to the health- related and non- health- related impacts of 
COVID-19 according to their contextual circumstances. 
Second, it can help the relevant bodies determine effec-
tive and efficient resource- mobilisation efforts, such as 
providing training for healthcare workers, supplying 
hospitals with necessary equipment, prioritising testing 
practices and distributing hand sanitiser and protective 
facemasks. Third, the information can be used as a guide 
for designing targeted travel restrictions or applying full 
or partial lockdowns as needed. Fourth, the evidence can 
stimulate further study on COVID-19 in the country.
Given Ethiopia’s large population size, variation in 
resources and vast geographic size, the risk of COVID-19 
infection, case severity and likelihood of death are likely 
to differ across regions, zones and districts, suggesting 
that local and context- specific interventions be imple-
mented. Therefore, this study aimed to map the vulner-
ability to infection, case severity and likelihood of death 




This study focused on Ethiopia, the second- most popu-
lous country in Africa, with an estimated population size 
of more than 115 million.9 Ethiopia has a total area of 
approximately 1.1 million square kilometres, making it 
the 10th largest country in Africa and the 27th largest in 
the world. The country has a tiered administrative system 
consisting of regional states (first level), zones (second 
level), woredas or districts (third level), and kebeles or 
neighbourhoods (fourth level).10 There are nine admin-
istrative regional states in Ethiopia, including Tigray, 
Afar, Amhara, Oromia, Somali, Benishangul- Gumuz, 
Harari, Gambella, and the Southern Nations, Nation-
alities, and Peoples’ Region (SNNPR), and two admin-
istrative cities (Addis Ababa and Diredawa). Four of 
these regional states (namely, Afar, Somali, Benishangul- 
Gumuz and Gambella) are relatively less developed, 
and categorised as developing regional states. They lag 
behind the rest of the country in all indicators related to 
human development and disease prevention and control 
programmes. The administrative units of Ethiopia (shape-
files) were obtained from the Database for Global Admin-
istrative Areas.11
Data sources and variable selection
The data for this study were assembled from multiple 
sources (table 1). Potential indicators were selected based 
on evidence of association with COVID-19 infection, 
case severity and death based on a literature review and 
the availability of country- wide representative data at a 
district geographic scale or lower (figure 1). Table 2 pres-
ents the evidence for the association between indicators 
and COVID-19, as well as the rationale for selecting these 
indicators for the study.
The following area- level demographic and socioeco-
nomic indicators were used as indicators of COVID-19 
infection and case severity: the average number of 
persons per household, the proportion of the popu-
lation aged ≥65 years, the proportion of males and the 
number of households in the lowest wealth quintile. All 
of these socioeconomic and demographic indicators 
were obtained from the latest Ethiopia Demographic and 
Health Survey (EDHS).12 A map showing the distribution 
of EDHS datapoints are available as online supplemental 
figure 1. Population density, estimated as the number of 
people per grid, was obtained from WorldPop.13
Connectivity indicators, which measure the population- 
level vulnerability to infection, were also captured using 
distance and time- bounded markers. Specifically, average 
travel time (measured in minutes) to the nearest city 
and proximity to international borders (measured in 
kilometres) were included to measure each area’s level 
of susceptibility to infection. Data on travel time to the 
nearest city, obtained from the University of Oxford’s 
Malaria Atlas Project (MAP), were used to quantify the 
accessibility of an area to high- density urban centres at 
a resolution of 1 km×1 km.14 Data on proximity to inter-
national borders were obtained from the EDHS spatial 
data repository and were used to measure15 the geodesic 
distance to the nearest international border in kilome-
tres, indicating the risk of cross- border transmission and 
the spread of COVID-19. Infection rates and the spread 
of COVID-19 were also positively correlated with the per 
capita public transportation use rate.16 Thus, to deter-
mine the nearest cross- country road to each location on 
the map, we obtained and applied data for major roads 
from the World Bank.17
It is evident that inadequate knowledge about COVID-19 
and a lack of awareness of prevention measures exacerbate 
community transmission of the disease.18 Therefore, we 
extracted data on adult literacy rate, access to media (such as 
radio, television and mobile phone messages) and knowledge 
about other infectious diseases (eg, HIV) from the EDHS as 
proxies for knowledge of COVID-19 prevention measures 
in each area of the country.12 According to the WHO, main-
taining good hand hygiene through regular washing with 
soap and water is one of the most effective preventative 
 on A
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Table 1 Data sources and definitions of indicators for the vulnerability of COVID-19 in Ethiopia
Indicators Data sources Spatial resolution Definitions
Demographic indicators
Male sex EDHS 2016 Latitude and longitude point Total number of male populations divided by the total number of 
people participated in the survey
Older age EDHS 2016 Latitude and longitude point Total number of people with age ≥65 years divided by the total 
number of people participated in the survey
Socioeconomic indicators
Population density WorldPop 1 km×1 km Number of people per square kilometre (grid)
Number of household 
members
EDHS 2016 Latitude and longitude point Average number of people living in a house
Low wealth index EDHS 2016 Latitude and longitude point Number of people with low wealth index (poorer and poorest) 
divided by the total number of people participated in the survey
Connectivity indicators
Travel times to cities MAP 1 km×1 km Travel time in minutes to the nearest city with a population of 
more than 50 000
Proximity to national borders DHS Spatial 
Repository
Latitude and longitude point The geodesic distance to the nearest international borders
Distance to major roads World Bank District Distance in km to cross- country round
Climatic indicators
Mean temperature WorldClime 1 km×1 km Annual mean environmental air temperature (°C)
Mean precipitation WorldClime 1 km×1 km Annual mean rainfall (mm)
Wind speed WorldClime 1 km×1 km Annual mean wind speed (m s-1)
Solar radiation WorldClime 1 km×1 km Annual mean solar radiation (kJ m-2 day-1)
Water vapour pressure WorldClime 1 km×1 km Annual mean water vapour pressure (kPa), equivalent to 
absolute humidity
Behavioural indicators
Khat chewing EDHS 2016 Latitude and longitude point Total number of people chewing khat in the last 1 month prior to 
the survey divided by the total number of people participating in 
the survey
Alcohol drinking EDHS 2016 Latitude and longitude point Total number of people drinking alcohol in the month prior to 
the survey divided by the total number of people participating in 
the survey
Cigarette smoking EPHI STEPS Latitude and longitude point Total number of people currently smoke cigarettes divided by 
the total number of people participating in the survey
Cooking inside the 
household
EDHS 2016 Latitude and longitude point Total number of households where cooking takes place inside 
the house without a separate building or outdoors (ie, exposure 
to smoke inside the home) divided by the total number of 
households in the survey
Use solid fuel for cooking EDHS 2016 Latitude and longitude point Number of households used some type of solid fuel (wood, 
dung, grass, crop) for cooking food divided by all households in 
the survey
Disease prevention knowledge indicators
Adult illiteracy rate EDHS 2016 Latitude and longitude point Total number of adults (aged 15 years and above) who had not 
attended school or who cannot read and write divided by the 
total number of adults participated in the survey
Access to listen to the radio EDHS 2016 Latitude and longitude point Total number of people who had not access to listen to the 
radio divided by total survey participants
Access to watch TV EDHS 2016 Latitude and longitude point Total number of people have no access to watch television 
divided by total survey participants
Mobile phone ownership EDHS 2016 Latitude and longitude point Total number of people have no access to mobile phone divide 
by the total number of survey participants
Knowledge toward HIV EDHS 2016 Latitude and longitude point Number of people with poor knowledge towards HIV divided by 
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measures for reducing the transmission of COVID-19.19 20 
Using the same data as above, we also assessed hand hygiene 
practices, access to water and the availability of handwashing 
stations in a household.
Previous studies have shown that underlying chronic 
comorbidities and behavioural factors such as cigarette, 
alcohol and khat consumption were associated with more 
severe COVID-19 infections.21 22 Data on khat chewing and 
the alcohol consumption rate were obtained from the EDHS 
2016,12 and data on cigarette smoking were obtained from 
the Ethiopia Public Health Institute Stepwise approach to 
Surveillance (STEPS) study.23 The STEP survey was also used 
to measure the prevalence of selected non- communicable 
diseases (NCDs) such as hypertension, heart disease and 
diabetes mellitus (DM).
The level of preparedness and readiness of health facilities 
to detect, manage and control the COVID-19 pandemic at 
a given location was measured using data from the Service 
Availability and Readiness Assessment (SARA) survey.24 For 
each geolocation, the obtained measures include the avail-
ability and readiness of facilities in terms of basic amenities 
and equipment, standard precautions, diagnostic capacities 
and essential medicines. In addition, data on service readi-
ness for specific diseases such as DM, chronic respiratory 
disease (CRD) and tuberculosis (TB), as well as the avail-
ability of intensive care units (ICUs) and laboratory facili-
ties, were obtained from this same survey. To augment the 
health facility data, we extracted population- level indicators 
on healthcare access and barriers to care from EDHS 2016.12
Finally, climatic data (temperature, precipitation, humidity 
and sunlight exposure) were obtained from the WorldClim 
V.2.0 Global Climate Database.25 These data were extracted 
at a spatial resolution of 30 s or ~1 km2 and were considered 
indicators of COVID-19 infection in this study.
Indicators Data sources Spatial resolution Definitions
Travel time to water sources EDHS 2016 Latitude and longitude point Mean travel time in minutes to obtain water source (ie, access 
to a water source)
Place for handwashing EDHS 2016 Latitude and longitude point Number of households have no fixed or mobile place for 
handwashing divided by total number of households in the 
survey
Soap or detergent availability 
for handwashing
EDHS 2016 Latitude and longitude point Number of households have no essential handwashing agents 
(ie, soap, and detergent) divided by total household in the 
survey
Comorbidities indicators
HTN EPHI STEPS Latitude and longitude point Total number of people with HTN divided by the total number of 
survey participants
DM EPHI STEPS Latitude and longitude point Total number of people with DM divided by the total number of 
survey participants
BMI EPHI STEPS Latitude and longitude point Mean body mass index
CVD EPHI STEPS Latitude and longitude point Total number of people with heart disease divided by total 
number of people in the survey
Cholesterol EPHI STEPS Latitude and longitude point Mean cholesterol level
HIV prevalence EDHS 2016 Latitude and longitude point Total number of people with HIV divided by survey participants
TB SMR EMOH District Standardised morbidity ratio (SMR) as measured by observed 
number of TB cases divided by the expected number of TB 
cases
Service availability and readiness indicators
Healthcare access problem EDHS 2016 Latitude and longitude point Difficulty of getting advice or treatment due to lack of money, or 
distance to a health facility
General service readiness 
and availability
EPHI SARA Latitude and longitude point Availability of equipment and supplies (ie, basic amenities, 
equipment, standard precautions, diagnostic capacity, essential 
medicines) necessary to provide general health services
ICU availability EPHI SARA Latitude and longitude point Availability of Critical Care Services (ICU) in hospitals
CRD readiness index EPHI SARA Latitude and longitude point Availability of specific services for chronic respiratory disease 
(CRD) diagnosis, management and follow- up
TB readiness index EPHI SARA Latitude and longitude point Availability of specific services for tuberculosis diagnosis, 
management and follow- up
Diabetes readiness index EPHI SARA Latitude and longitude point Availability of specific service for diabetes diagnosis and 
management and follow- up
EDHS, Ethiopia ddemographic and Health Survey; EMOH, Ethiopia Ministry of Health; EPHI, Ethiopia Public Health Institute; G- Econ, Geographically 
based Economic data; ICU, intensive care unit; MAP: SRTM, Malaria Atlas Project; Shuttle Radar Topography Mission; UN OCHA, United Nation 
Office for Coordination of Humanitarian Affairs; SARA, Service Availability and Readiness Assessment.
Table 1 Continued
 on A
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Geospatial data processing
All data were georeferenced using a geographical informa-
tion system, ArcGIS V.10.6.1 software (ESRI, Redlands, Cali-
fornia, USA). The ideal resolution for spatial analysis was a 
latitude and longitude point that represented the location of 
the data cluster (point- level data), but when these were not 
available, we geolocated the available data to the smallest 
geographical areal unit, typically representing an administra-
tive unit such as village or districts. In instances when the lati-
tude and longitude coordinates of the village or district were 
not available in the dataset, centroids of the village or districts 
were also identified using Google Maps. A very small rectan-
gular polygon (fishnet) with its centroid (fishnet centroid) 
covering the whole territory of Ethiopia was created using 
a sampling tool under the data management tools in the 
ArcToolbox (figure 2). The fishnet centroid contained a 
unique identification number and was used as a common 
georeferenced system to process, join and extract the raster 
and vector data collected from various sources. All vector 
data (point, polygon and line) were converted to raster data 
using geostatistical methods.26 Raster grids were then resam-
pled to the common georeferenced system at a spatial resolu-
tion of 1 km×1 km. Finally, a raster mask covering the entire 
country was created by clipping smaller spatial units from a 
large global raster data source.
Statistical analyses
Geostatistical techniques such as spatial autocorrelation, 
kriging and semivariograms were applied to create a predic-
tion grid surface from a scattered set of points.27 Kriging 
assumes that the distance or direction between sample points 
reflects a spatial correlation that can be used to explain varia-
tion in the surface.28 Since the variables had different units of 
measurement, the datasets were normalised using a min- max 
approach to a standard scale ranging from 0 (the lowest risk) 
to 100 (the highest risk).29 After normalisation, the indica-
tors were averaged to create a vulnerability index, measuring 
the risk of COVID-19 for each geolocation.30 The vulnera-
bility indices were calculated separately for each domain, 
namely, the vulnerability to infection, case severity and like-
lihood of death from COVID-19. The three domains were 
then averaged to produce the overall COVID-19 vulnerability 
index. Given that COVID-19 is a new virus, there is a lack of 
evidence for assigning weights for each indicator. Hence, 
equal weight was given to all indicators when calculating 
the arithmetic mean for the vulnerability indices. However, 
we also used principal component analysis (PCA) and 
geometric mean methods, which produced broadly similar 
results (online supplemental figures 2 and 3). The risk maps 
were then created separately for infection, case severity, 
service preparedness and death from the composite index 
using geostatistical tools in ArcGIS. All data transformations 
were performed in R.31 All items included in this study are 
available in the STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) Statement checklist 
(online supplemental table 1).
RESULTS
Vulnerability to COVID-19 infection
Figure 3 shows the vulnerability map of COVID-19 infec-
tion in Ethiopia. The map highlights that most parts of the 
country are likely to have a relatively high vulnerability and be 
at substantial risk for COVID-19 infection. Most parts of the 
country are identified as vulnerable to COVID-19 infection, 
with the exception of Addis Ababa and the north- western 
Somali region. The peripheral areas of the country bordering 
Djibouti, Somalia, Eritrea and South Sudan appeared to be 
vulnerable to COVID-19 infection. These outlying areas are 
characterised by a low level of geographical connectivity and 
low scores for disease knowledge, hand hygiene and socio-
economic indices (online supplemental figure 4). They also 
have certain climatic factors that were found to be important 
indicators of COVID-19 transmission.
Vulnerability to severe cases of COVID-19 infection
Areas across the Amhara region and most parts of the 
Oromia region are likely to experience severe forms of 
COVID-19 that require hospitalisation and ICU admission. 
Some parts of the SNNPR are also expected to be at high risk 
of severe COVID-19 infections. The combination of demo-
graphic (high proportion of older adults), comorbidity (high 
prevalence of hypertension, DM, obesity, HIV and TB), and 
behavioural and economic indicators (high proportion of 
smokers and high level of alcohol and khat consumption, 
interior cooking and solid fuel use) renders these parts of 
the country at a higher risk of severe forms of COVID-19. 
Figure 4 shows the levels of vulnerability to severe forms of 
COVID-19.
Vulnerability to death from COVID-19
People living around border areas in Ethiopia are at a high 
risk for COVID-19- related death, as illustrated in figure 5. 
Districts and zones in the Benishangul- Gumuz, Gambela, 
Afar, SNNPR, Dire Dawa, Southwest Somali, Northwest 
Figure 1 Indicators for the vulnerability of COVID-19 
infection, severity, service, preparedness and related death. 
CVD, cardiovascular disease prevalence; DM, diabetes 
mellitus; ICU, intensive care unit; TB, tuberculosis.
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Demographic indicators   
Male sex Severity Death from and severity of COVID-19 was strongly associated with being male 
(HR 1.99, 95% CI 1.88 to 2.10)
Williamson et al40
Older age Severity Older than 65 years were risk factors for disease progression in patients with 
COVID-19 (OR=6.06, 95% CI 3.98 to 9.22)
Zheng et al22
Socioeconomic indicators
Population density Infection High population density is a risk factor for COVID-19 infection Ahmadi et al41
Number of household 
members
Infection Areas with a higher percentage of households with more than one person per 
room had a higher incidence of COVID-19
Ahmad et al42
Low wealth index Infection Socioeconomic deprivation (RR 1.26 per SD increase in Townsend Index) 
associated with COVID-19 infection
Ho et al43
Connectivity indicators   
Travel times to cities Infection The distance between Wuhan and other cities was inversely associated with the 
numbers of COVID-19 cases in that city
Zheng et al44
Proximity to national 
borders
Infection Cross- country moment is a risk factor for COVID-19 transmission and 
importation
Chinazzi et al45
Distance to major roads Infection Spread of COVID-19 was correlated positively with public transportation per 
capita
Ayenew et al16.
Climatic indicators   
Mean temperature Infection Low ambient temperatures are associated with more rapid spread of COVID-19 Holtmann et al46
Mean precipitation Infection Countries with higher rainfall measurements showed an increase in COVID-19 
transmission
Sobral et al47
Wind speed Infection Areas with low values of wind speed associated with a high rate of COVID-19 
infection
Ahmadi et al41
Solar radiation Infection Areas with low values of solar radiation exposure associated with a high rate of 
COVID-19 infection
Ahmadi et al41
Water vapour pressure Infection High humidity reduces the transmission of COVID-19. Water vapour pressure 
negatively correctly with COVID-19 infection.
Wang et al48 49
Behavioural indicators   
Khat chewing Severity There is an association between khat chewing and chronic illness such as HIV 
infection, elevated diastolic blood pressure
Basker50
Alcohol drinking Severity Patients with alcohol use disorders at increased risk for COVID-19 Testino21
Cigarette smoking Severity Current smoking was a risk factor for disease progression in patients with 
COVID-19 (OR=2.51, 95% CI 1.39 to 3.32)
Zheng et al22
Cooking inside the 
household
Severity Areas with a higher percentage of incomplete kitchen facilities had a higher 
incidence of, and mortality associated with, COVID-19
Ahmad et al42
Use solid fuel for cooking Severity Areas with a higher percentage of incomplete kitchen facilities had a higher 
incidence of, and mortality associated with, COVID-19
Ahmad et al42
Disease prevention knowledge indicators   
Adult illiteracy rate Infection Adult learning education is a tool to contain the COVID-19 pandemics Lopes et al51
Access to listen to radio Infection Access to media is a crucial factor in public health responses to an outbreak Ayedee and 
Manocha52




Mobile phone ownership Infection Mobile phone calls and text messages help for the diagnosis, management and 
control of infectious diseases
Wood et al53
Knowledge towards HIV Infection Knowledge towards an infectious disease such as HIV can help to control the 
transmission of the diseases
Bertozzi et al54
Hand hygiene indicators   
Travel time to water sources Infection Adequate water supply is essential for the control of COVID-19 infection WHO55
Place for handwashing Infection Hand washing is recommended by WHO for the control of COVID-19 infection WHO56
Continued
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Amhara, Western Tigray, and Western and Eastern Oromia 
regions are at high risk for COVID-19- related death. The level 
of service preparedness and readiness to mitigate the health 
effects of COVID-19 appears to be very low in these regions 
(figure 6). Ethiopia’s border regions have inadequate ICU 
availability and laboratory capacity as well as limited health-
care access. They also have low general and service- specific 
readiness, as shown in figure 6.
DISCUSSION
This is the first study that maps vulnerability to COVID-19 
infection, severe cases and associated death in Ethiopia at a 
high resolution. This is also the first study that has attempted 
to present the degree of service preparedness for COVID-19 
across the country.
We found that most parts of the country are vulnerable 
to COVID-19 infections, and the greatest burden might be 
outside of Addis Ababa. It is likely that compared with other 
regions, a higher proportion of people from the Amhara 




Soap or detergent 
availability for handwashing
Infection Availability of soap or detergent is essential to keep hand hygiene for the 
prevention of COVID-19 infection
WHO56
Comorbidity indicators   
HTN Severity Hypertension was statistically significant with a higher rate of servery and death 
(OR=2.72, 95% CI 1.60 to 4.64)
Zheng et al22
DM Severity Death from COVID-19 was associated with DM (HR 1.50, 95% CI 1.40 to 1.60) 
1.50
Williamson et al40
BMI Severity Death from COVID-19 was associated with higher BMI (HR 1.27, 95% CI 1.18 to 
1.36)
Williamson et al40
CVD Severity Cardiovascular disease was significantly associated with higher COVID-19 
servility and death (OR=5.19, 95% CI 3.25 to 8.29)
Zheng et al22
HIV prevalence Severity Mortality from COVID-19 was associated with immunosuppression (HR 1.69, 
95% CI 1.21 to 1.34)
Williamson et al40
TB SMR Severity Respiratory diseases were significantly associated with COVID-19 death and 
severity (OR=5.15, 95% CI 2.51 to 10.57)
Zheng et al22
Service availability and readiness indicators   
Healthcare access problem Death Healthcare resource availability is associated with COVID-19 mortality Ji et al6
General service readiness Death General health service preparedness is essential for combating the COVID-19 
pandemic
WHO57
ICU availability Death Lack of critical care unite increase the risk of death from COVID-19 Murthy et al58
CRD readiness Death Cardiorespiratory disease (CRD) is a risk factor for COVID-19- related death Zheng et al22
TB readiness Death TB determinants outcomes of patients with COVID-19 Tadolini et al59
Diabetes readiness Death Diabetes affects the prognosis of patients with COVID-19 Zheng et al22
. EDHS, Ethiopia Demographic and Health Survey; EMOH, Ethiopia Ministry of Health; EPHI, Ethiopia Public Health Institute; G- Econ, Geographically 
based Economic data; ICU, intensive care unit; MAP: SRTM, Malaria Atlas Project; Shuttle Radar Topography Mission; UN OCHA, United Nation 
Office for Coordination of Humanitarian Affairs; SARA, Service Availability and Readiness Assessment.
Table 2 Continued
Figure 2 Rectangular polygon (fishnet), fishnet centroids 
and raster mask covering the whole territory of Ethiopia.
Figure 3 Vulnerability map to COVID-19 infection in 
Ethiopia.
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country, will develop severe forms of COVID-19 leading to 
hospitalisation and ICU admission. Border areas of the 
country are also expected to face a higher risk of death than 
areas located in the central regions. The findings of this study 
are of paramount importance in preventing and controlling 
COVID-19 transmission and in designing targeted inter-
ventions, such as enacting travel restrictions, distributing 
preventative masks and determining which areas to prioritise 
if a COVID-19 vaccine becomes available. As some of these 
areas also have lower preparedness scores and low general 
and service- specific readiness scores, the findings have wider 
implications for allocating resources and strengthening the 
healthcare system after the COVID-19 pandemic.
Despite the disproportionately high infection rate in Addis 
Ababa at present (online supplemental figure 5), we found 
that the risk of COVID-19 infection is likely to become rather 
high in other regions. The high infection rate in Addis Ababa 
at this initial stage is expected, given that Addis Ababa is a 
major travel hub and Bole International Airport, located in 
the city, is one of the largest international airports in Africa. 
This exposes the city to a higher risk of imported cases and, 
subsequently, to an early surge of infections, leaving the areas 
outside the city at a higher risk of later infection. Second, 
we considered multifaceted risk factors (indicators) for 
COVID-19 infection in our geospatial model. This means 
that although the city has a high degree of connectivity, it 
is also characterised by higher scores for information pene-
tration, knowledge of disease prevention and hand hygiene 
practices that could help slow the rate of infection in the 
city.12 Third, Addis Ababa has relatively better and more 
consistent test- and- contact tracing practices than in other 
parts of the country, which means that the chance of new 
infections being detected in the city are much greater than in 
other parts of the country.5 Future efforts to expand testing 
and tracing practices in other areas of the county are likely 
to increase the extent of confirmed infections in those other 
areas. Recent studies have demonstrated that effective social 
distancing and contact tracing can significantly reduce the 
rate of infection.32 33 These interventions should be strength-
ened and expanded to areas identified as high risk in this 
study.
Our study also showed that the risk for severe cases of 
COVID-19 infection is high in most parts of the Amhara and 
Oromia regions. This may be due to the high prevalence of 
NCDs, which are associated with severe cases of COVID-19. 
Previous studies have revealed that the burden of NCDs, such 
as DM and hypertension, is high in these two regions.23 34 35
Our study also revealed that peripheral areas sharing 
international borders are likely to see a greater number of 
COVID-19- related deaths. The high risk of death along the 
border areas might be attributed to low preparedness in 
case management and weak healthcare systems. In contrast, 
although the Amhara and Oromia regions may have more 
severe cases, the preparedness indicators show that the 
regions are better equipped to cope with these anticipated 
Figure 4 Vulnerability map to COVID-19 severity in Ethiopia.
Figure 5 Vulnerability map to death from COVID-19 in 
Ethiopia.
Figure 6 Vulnerability map to service preparedness for 
COVID-19 in Ethiopia.
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severe cases. However, our study suggests that additional 
preparation and capacity strengthening are needed mainly 
in the following areas: emergency response systems, case 
detection and capacity to care for patients. It is also equally 
important that hospitals have adequate supplies, healthcare 
personnel and life- saving medical intervention resources. 
Despite encouraging efforts by the Ethiopian government 
and stakeholders to prepare the healthcare system for the 
pandemic, the existing healthcare services in the country 
may face unprecedented challenges and crises due to the 
surge of patients that will require hospitalisation and ICU 
services at the same time. This can, however, be eased by 
implementing public health and social measures at the indi-
vidual, community and public authority levels to prevent 
infections and subsequent health, economic and social 
consequences.36 Studies have shown that implementing non- 
pharmaceutical interventions such as physical distancing, 
mask use and closure of schools, especially during the early 
stages of infection, can reduce transmission and subsequent 
potential public health and economic crises.37
Further, we found notable regional disparities in health 
system preparedness and readiness levels in the country. This 
is important because if the healthcare system is well equipped 
to prevent and mitigate the spread of the pandemic, then the 
mortality rate from the disease can be markedly reduced.38 
However, we observed that Ethiopia’s border regions (ie, 
Benishangul- Gumuz, Gambella, Afar and Somali) have low 
preparedness levels. Nevertheless, comparisons between the 
border regions and other regions of the country need to be 
treated with care because Ethiopia in general has very low 
doctor- to- resident (1 doctor per 10 000 people) and hospital 
bed- to- population (3 hospital beds per 10 000 people) 
ratios.39 Several long- term, medium- term and short- term 
strategies can be implemented to mitigate these problems: 
(1) providing short- term training for potential actors such 
as community leaders, students, and traditional and modern 
medical practitioners; (2) recruiting additional staff to work 
in COVID-19- related healthcare; (3) establishing COVID-19 
clinics and changing outpatient rooms to emergency clinics; 
(4) collaborating with private hospitals ahead of surges so 
that they can be used in the case such surges occur; and (5) 
establishing mobile clinics and temporary admission rooms 
in highly vulnerable areas.
Strength and limitations
This study has several strengths. First, the current study was 
conducted at a spatial resolution of 1 km×1 km across the 
entire territory of Ethiopia. Second, it incorporated a wide 
range of indicators from multiple sources. Third, it applied 
rigorous geospatial techniques, including spatial autocorrela-
tion, kriging and semivariograms, to provide the best possible 
prediction maps. Finally, we produced vulnerability mapping 
for infection or transmission, case severity and associated 
death separately to assist with policy interventions related to 
each risk.
However, it is important to note some potential limita-
tions of the study when interpreting the findings. First, the 
results need constant updating, as some of the variables used 
in the study may change overtime. Second, the data used in 
this study were not collected in the same year and the results 
might be changed if recently available data were used in the 
analysis. However, many of the variables used in this study 
were static and may not change over time. Moreover, we 
used the most recently available data for non- static variables 
such as EDHS data. Third, ongoing political turmoil in the 
country means that the dynamics of transmission may change 
depending on the location and severity of these incidents. 
For example, in areas of low security resulting from active 
conflict, the local health systems might be ill- prepared to 
prevent and control COVID-19. Insecurity also may generate 
unpredictable population movements, and this in turn could 
exacerbate infection dynamics in the country. Fourth, the 
calculation of the composite risk factor index was based on 
an unweighted average under the assumption that all indi-
cators have equal importance, which may or may not be the 
case. Some of the variables included in our score may have 
greater effects on vulnerability to infection, case severity and 
likelihood of death than others. Giving equal weight for 
all these variables may influence the findings of our study, 
but the exact effect is hard to tell. However, we have calcu-
lated a weighted index using PCA as an alternative method, 
which produced broadly similar results (online supplemental 
figures 2 and 3). Lastly, some important indicators, such as 
psychosocial and clinical factors (eg, mental illness, quality of 
life and social support), were not captured in our modelling 
due to the lack of geocoded data.
CONCLUSIONS
Although nearly three- quarters of the current COVID-19 
cases reported in Ethiopia are concentrated in and 
around Addis Ababa, this study predicts that over time, 
the risk of COVID-19 infection will be higher across most 
other parts of the country. A higher proportion of people 
from the Amhara region, most of the Oromia region and 
some parts of the SNNPR will develop severe cases of 
infection. Additionally, the risk of death will be higher in 
the regions of the country with low preparedness scores 
for COVID-19 response. Hence, the preventative and 
control measures that are currently in place in the capital 
city should be strengthened and extended to regional 
areas, especially to high- risk areas, to prevent and miti-
gate the risk of COVID-19 infection, lower the number of 
severe cases and limit the number of associated deaths in 
Ethiopia.
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Supplemental Figure 1: A map showing the distribution of the Ethiopia Demographic and 
Health Survey (EDHS 2016) datapoints. 
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S Figure 2a. COVID-19 infection risk map in Ethiopia, created 
based on a geometric mean 
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Supplemental Figure 3: Vulnerability maps of COVID-19 infection, severity, preparedness, and 
death in Ethiopia, created based on a principal component analysis (PCA) as alternative 
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Supplemental Figure 5: Number of COVID-19 confirmed cases at regional level in Ethiopia on 
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(d) If applicable, describe analytical methods taking account of sampling strategy NA 
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Results  
Participants 13 (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined 
for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
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(c) Consider use of a flow diagram Figure 1 
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Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the 
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15 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open





Supplemental Figure 1: A map showing the distribution of the Ethiopia Demographic and 
Health Survey (EDHS 2016) datapoints. 
 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 2a. COVID-19 infection risk map in Ethiopia, created 
based on a geometric mean 
S Figure 2b. COVID-19 severity risk map in Ethiopia, created based on a 
geometric mean 
  
S Figure 2c. Death risk map of COVID-19 in Ethiopia, created 
based on a geometric mean 
S Figure 2d. Service preparedness map of COVID-19 in Ethiopia, created 
based on a geometric mean 
Supplemental Figure 2: Vulnerability maps of COVID-19 infection, severity, preparedness, and 







BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 3a. COVID-19 infection risk map in Ethiopia, created based 
on a geometric mean 
S Figure 3b. COVID-19 severity risk map in Ethiopia, created 
based on a geometric mean 
  
S Figure 3c. Death risk map of COVID-19 in Ethiopia, created based on 
a geometric mean 
S Figure 3d. Service preparedness map of COVID-19 in 
Ethiopia, created based on a geometric mean 
 
Supplemental Figure 3: Vulnerability maps of COVID-19 infection, severity, preparedness, and 
death in Ethiopia, created based on a principal component analysis (PCA) as alternative 





BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 4a. Average number of people living in a house S Figure 4b. Percentage of population have no access to radio  
  
S Figure 4b. Percentage of the population who have not access to 
mobile phone 
S Figure 4d. Percentage of households who have not hand washing 
facilities 








BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




Supplemental Figure 5: Number of COVID-19 confirmed cases at regional level in Ethiopia on 













BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-044606:e044606. 11 2021;BMJ Open, et al. Alene KA
6 
 





Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1  




Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 5 
Objectives 3 State specific objectives, including any prespecified hypotheses 6 
Methods  
Study design 4 Present key elements of study design early in the paper 6 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-
up, and data collection 
6 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 6, 7 &8 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
6, 7 &8 
Data sources/ 
measurement 
8  For each variable of interest, give sources of data and details of methods of assessment 
(measurement). Describe comparability of assessment methods if there is more than one group 
6, 7, 8 & 
Table 1 
Bias 9 Describe any efforts to address potential sources of bias 9 
Study size 10 Explain how the study size was arrived at NA 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which 
groupings were chosen and why 
8 & 9 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 8 & 9 
(b) Describe any methods used to examine subgroups and interactions 8 & 9 
(c) Explain how missing data were addressed 8 & 9 
(d) If applicable, describe analytical methods taking account of sampling strategy NA 
(e) Describe any sensitivity analyses 9 
Results  
Participants 13 (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined 
for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
9 & 10 
(b) Give reasons for non-participation at each stage 9 & 10 
(c) Consider use of a flow diagram Figure 1 
Descriptive data 14 (a) Give characteristics of study participants (eg demographic, clinical, social) and information on 
exposures and potential confounders 
Table 1 
(b) Indicate number of participants with missing data for each variable of interest NA 
Outcome data 15 Report numbers of outcome events or summary measures 9 & 10 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision 
(eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were 
included 
NA 
(b) Report category boundaries when continuous variables were categorized NA 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time 
period 
NA 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 9 
Discussion  
Key results 18 Summarise key results with reference to study objectives 10 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss 
both direction and magnitude of any potential bias 
13 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other relevant evidence 
10-13 
Generalisability 21 Discuss the generalisability (external validity) of the study results 13 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the 
original study on which the present article is based 
15 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open





Supplemental Figure 1: A map showing the distribution of the Ethiopia Demographic and 
Health Survey (EDHS 2016) datapoints. 
 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 2a. COVID-19 infection risk map in Ethiopia, created 
based on a geometric mean 
S Figure 2b. COVID-19 severity risk map in Ethiopia, created based on a 
geometric mean 
  
S Figure 2c. Death risk map of COVID-19 in Ethiopia, created 
based on a geometric mean 
S Figure 2d. Service preparedness map of COVID-19 in Ethiopia, created 
based on a geometric mean 
Supplemental Figure 2: Vulnerability maps of COVID-19 infection, severity, preparedness, and 







BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 3a. COVID-19 infection risk map in Ethiopia, created based 
on a geometric mean 
S Figure 3b. COVID-19 severity risk map in Ethiopia, created 
based on a geometric mean 
  
S Figure 3c. Death risk map of COVID-19 in Ethiopia, created based on 
a geometric mean 
S Figure 3d. Service preparedness map of COVID-19 in 
Ethiopia, created based on a geometric mean 
 
Supplemental Figure 3: Vulnerability maps of COVID-19 infection, severity, preparedness, and 
death in Ethiopia, created based on a principal component analysis (PCA) as alternative 





BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




S Figure 4a. Average number of people living in a house S Figure 4b. Percentage of population have no access to radio  
  
S Figure 4b. Percentage of the population who have not access to 
mobile phone 
S Figure 4d. Percentage of households who have not hand washing 
facilities 








BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open




Supplemental Figure 5: Number of COVID-19 confirmed cases at regional level in Ethiopia on 













BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-044606:e044606. 11 2021;BMJ Open, et al. Alene KA
6 
 





Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1  




Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 5 
Objectives 3 State specific objectives, including any prespecified hypotheses 6 
Methods  
Study design 4 Present key elements of study design early in the paper 6 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-
up, and data collection 
6 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 6, 7 &8 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
6, 7 &8 
Data sources/ 
measurement 
8  For each variable of interest, give sources of data and details of methods of assessment 
(measurement). Describe comparability of assessment methods if there is more than one group 
6, 7, 8 & 
Table 1 
Bias 9 Describe any efforts to address potential sources of bias 9 
Study size 10 Explain how the study size was arrived at NA 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which 
groupings were chosen and why 
8 & 9 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 8 & 9 
(b) Describe any methods used to examine subgroups and interactions 8 & 9 
(c) Explain how missing data were addressed 8 & 9 
(d) If applicable, describe analytical methods taking account of sampling strategy NA 
(e) Describe any sensitivity analyses 9 
Results  
Participants 13 (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined 
for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed 
9 & 10 
(b) Give reasons for non-participation at each stage 9 & 10 
(c) Consider use of a flow diagram Figure 1 
Descriptive data 14 (a) Give characteristics of study participants (eg demographic, clinical, social) and information on 
exposures and potential confounders 
Table 1 
(b) Indicate number of participants with missing data for each variable of interest NA 
Outcome data 15 Report numbers of outcome events or summary measures 9 & 10 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision 
(eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were 
included 
NA 
(b) Report category boundaries when continuous variables were categorized NA 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time 
period 
NA 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 9 
Discussion  
Key results 18 Summarise key results with reference to study objectives 10 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss 
both direction and magnitude of any potential bias 
13 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of 
analyses, results from similar studies, and other relevant evidence 
10-13 
Generalisability 21 Discuss the generalisability (external validity) of the study results 13 
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the 
original study on which the present article is based 
15 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-044606:e044606. 11 2021;BMJ Open, et al. Alene KA
